Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12. - Wikidata - wikimedia - TriplyDB

Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12.

Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12.

http://www.wikidata.org/entity/Q37470294

about

Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular Perspectives Predicted molecular signaling guiding photoreceptor cell migration following transplantation into damaged retina.The Anti-inflammatory Protein TSG-6 Regulates Chemokine Function by Inhibiting Chemokine/Glycosaminoglycan Interactions Multiple glycosaminoglycan-binding epitopes of monocyte chemoattractant protein-3/CCL7 enable it to function as a non-oligomerizing chemokine.Emerging concepts and approaches for chemokine-receptor drug discovery.Characterization of the chemokine CXCL11-heparin interaction suggests two different affinities for glycosaminoglycans.Chemokine cooperativity is caused by competitive glycosaminoglycan binding.Chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3 regulate vascular α₁-adrenergic receptor function.Heparan sulfate inhibits hematopoietic stem and progenitor cell migration and engraftment in mucopolysaccharidosis I.Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies.Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation Touch of chemokines.Differential structural remodelling of heparan sulfate by chemokines: the role of chemokine oligomerization.CCL2 nitration is a negative regulator of chemokine-mediated inflammation.Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function Chemokines: established and novel targets in atherosclerosis.Structure-based design of decoy chemokines as a way to explore the pharmacological potential of glycosaminoglycans.G protein-coupled receptors in rheumatology.The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease.The sweet spot: how GAGs help chemokines guide migrating cells.Essential role of immobilized chemokine CXCL12 in the regulation of the humoral immune response.Regulation of Chemokine Function: The Roles of GAG-Binding and Post-Translational Nitration Homeostatic and tissue reparation defaults in mice carrying selective genetic invalidation of CXCL12/proteoglycan interactions.CXCL12γ isoform is expressed on endothelial and dendritic cells in rheumatoid arthritis synovium and regulates T cell activation.Endothelial expression of CXCR7 and the regulation of systemic CXCL12 levels.

P2860

Q26782778-3E22C155-04EA-45EE-8130-955B42295AAE Q27335140-42AC79C5-A713-40B1-ABA7-43967DD4C7E2 Q28115376-4645BDEF-F1B7-40AE-8FE3-E7E5FC1CED9B Q33652172-6B7E5133-A6E0-477E-93DF-9D4C68CEC6F0 Q33763369-91408050-FB09-4906-AA22-FCDD032D6D53 Q33885243-E759D23E-CBC7-4055-94E9-892408DC25F9 Q34344569-CD176E40-99C4-4D7A-A4B9-96A7D7663A82 Q34416235-47DDF950-CE15-47F4-8642-F071A8BE86D5 Q34774580-2F5FF2E9-DBDC-4FF1-B725-7E5994754EF8 Q35528569-1DB563D8-2763-448B-AD83-7475516CB328 Q35849570-FA0C752C-697A-47FE-9A38-32470E410229 Q36090029-2F8EEE54-F167-49D2-9BA4-42F4F9C73A7D Q37637122-59B1ECD6-E6ED-4607-B8F8-22B48B7B99FD Q37698743-90AE6BE5-2A88-4325-A29C-5AD17C81F506 Q37827607-ACDEEF40-D27E-45E6-8700-93542CBAC6CD Q37950973-AC8E0CDD-D259-4211-9A51-9655583F13E0 Q38022773-CF027FAE-58F5-484D-BEDA-78825FEFAAA5 Q38209549-A5368257-0A81-4D9B-9139-934F39C96455 Q38223391-F6555A3F-C61B-4D57-9BB7-CFE12673C34C Q38678399-F28F2FB9-12EE-4A53-8E59-BF72013387D1 Q40334354-F2F1D30D-E384-4D67-BD3C-371851D77FD8 Q41573564-4B10B8ED-E48D-45C9-98E6-88D4E85C514F Q41964485-12C7DAAB-28E6-4DC0-8B04-8AC5EE3657EE Q54346253-561E9046-B945-43AD-BCF3-2CDADD48340D Q55057465-351DAADE-86B5-4319-A138-AD505C393748

P2860

Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12.

http://www.wikidata.org/entity/Q37470294

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 August 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12.

@en

Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12.

@nl

type

label

Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12.

@en

Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12.

@nl

prefLabel

Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12.

@en

Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12.

@nl

P1433

Q37470294-47C9DEE1-3F86-41F7-98BD-A292ECCDAA35

P1476

Q37470294-BE5FAB38-585A-42E7-B348-CCCE827569C5

P2093

Q37470294-2C7F914A-278A-450B-BDB7-B716936F054B

Q37470294-6EBEE065-1699-4182-9EC5-2B7DB89FF261

Q37470294-9017E052-F00C-4D2D-B24A-B967FCB4331D

Q37470294-92B069EF-B852-4576-A9B7-94F4D322439D

P2860

Q37470294-03C27DB5-ABE8-4B3B-A046-DB4E1411A2D3

Q37470294-056AF027-6380-4266-8BB1-8DDF7DDE895C

Q37470294-079D33BF-2262-4B3C-A647-28850D238B48

Q37470294-0A8B761B-A15F-4D6B-B561-4317CA4A3407

Q37470294-1C712F8D-9CA3-4955-A9EC-BEB089522F65

Q37470294-1F78952F-54B7-4E1A-8DBE-725DB93E224A

Q37470294-27D5925B-915E-494E-A56A-D05FBB7C5E6C

Q37470294-2AC9DAC3-0E97-4025-8961-D30A5CBC05B2

Q37470294-2B9C71D0-5C92-4FB0-9372-01A12B5428EA

Q37470294-2DA4A190-98E0-48DF-826C-6C22CB3C9460

P304

Q37470294-0E278B06-BDDE-4AFF-BF7D-502C27DA6F69

P31

Q37470294-8AFA4203-F05B-4F2B-A3BF-6D4AB895B243

P356

Q37470294-0B8367D9-5F0F-4645-9E60-F30BBC918BA0

P407

Q37470294-3F396604-5A6F-4BC1-9AAF-C8F93A5EA560

P433

Q37470294-5E391036-05D9-4BC0-B6CC-A5232E90976C

P478

Q37470294-D85BEE29-D983-414F-98BC-B4E286494C9D

P577

Q37470294-373C71DE-5B17-448D-96AC-D0E849B2E71D

P5875

Q37470294-582E3BDB-E326-4889-A6D6-405FB08DA12E

P698

Q37470294-5DE79F10-0578-4FAD-9055-E74C81B39CBA

P921

Q37470294-CB172592-09F4-4272-A787-DED974F3BC96

P932

Q37470294-3AB63924-E918-4391-ACEE-212F317E0795

P356

P1433

P1476

Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12.

@en

P2093

Graeme O'Boyle

http://www.w3.org/2001/XMLSchema#string

John A Kirby

http://www.w3.org/2001/XMLSchema#string

Paul Mellor

http://www.w3.org/2001/XMLSchema#string

Simi Ali

http://www.w3.org/2001/XMLSchema#string

P2860

Involvement of chemokine receptors in breast cancer metastasis

A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)

The MCP/eotaxin subfamily of CC chemokines

The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins

Mast cells in newly formed lining tissue during acute inflammation: a six day air pouch model in the mouse

G-protein-coupled receptors and signaling networks: emerging paradigms.

Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines

Chemokines and breast cancer: a gateway to revolutionary targeted cancer treatments?

Air-pouch models of inflammation and modifications for the study of granuloma-mediated cartilage degradation.

Distinct mechanisms of agonist-induced endocytosis for human chemokine receptors CCR5 and CXCR4

P304

3906-3916

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1096/FJ.09-134643

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26728967

http://www.w3.org/2001/XMLSchema#string

P698

19667120

http://www.w3.org/2001/XMLSchema#string

P921

P932

2791779

http://www.w3.org/2001/XMLSchema#string